Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New site revision v3.3.4 appears in the history, indicating a minor update; no study data or page content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:34:39.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Outcome Measures (Results), References, and Study Status, and updated revision to v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T09:24:42.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The record history adds a 'Results Posted' entry and updates multiple results-related sections (Outcome Measures, Adverse Events, Baseline Characteristics, Participant Flow, IPD Sharing, Study Description/Design) with a new version dated 2025-11-14, replacing the previous 'Results Submitted' entry.
    Difference
    0.6%
    Check dated 2025-12-08T23:56:04.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page history shows a new revision v3.3.2 added and the previous revision v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:51:26.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The latest version adds a 'Results Submitted' entry and removes 'No Results Posted' in the History. It is labeled Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:57:15.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Removed a site-wide operating-status notice about government funding and NIH/Clinical Center status (including links to cc.nih.gov and opm.gov). The notice previously appeared at the top of the page.
    Difference
    0.2%
    Check dated 2025-11-17T07:16:41.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.